Viswanathan Ravi

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Viswanathan Ravi
CIK #0001479386
EDGAR Form CIK 2011 - 2025
3 [0001479386]
4 [0001479386]
Form 3/4/5 Subject 2011 - 2025
Duolingo, Inc.
NewView Capital Fund I, L.P.
Viswanathan Ravi
NewView Capital Partners I, LLC
Sandell Scott D
PhaseBio Pharmaceuticals Inc
Kerins Patrick J
Barrett M James
Baskett Forest
NEA 13 GP, Ltd
NEA Partners 13, Limited Partnership
Mott David M
New Enterprise Associates 13 LP
Barris Peter J
Marker Therapeutics, Inc.
Elastic N.V.
Adaptimmune Therapeutics PLC
Aveo Pharmaceuticals Inc
Ardelyx Inc
Mulesoft Inc
Surface Oncology, Inc.
NEA Partners 14, L.P.
Tracon Pharmaceuticals, Inc.
NEA 14 GP Ltd
Cascadian Therapeutics, Inc.
TESARO, Inc.
Oruka Therapeutics, Inc.
Ra Pharmaceuticals, Inc.
Appian Corp
Synlogic Inc
Genocea Biosciences Inc
Strongbridge Biopharma plc
X4 Pharmaceuticals, Inc
Care.com Inc
Rhythm Pharmaceuticals Inc
Regulus Therapeutics Inc.
Mersana Therapeutics, Inc.
Achaogen, Inc.
Sorrento Tech, Inc.
Interleukin Genetics Inc
Epizyme, Inc.
Avalo Therapeutics, Inc.
Champions Oncology Inc
Box Inc
Cvent Inc
Dermira, Inc.
Loxo Oncology, Inc.
Aerohive Networks Inc
Kolluri Krishna Kittu
Weller Harry R
Crescent Biopharma Inc
Drant Ryan D
Omthera Pharmaceuticals, Inc.
Clovis Oncology, Inc.
Workday, Inc.
Millennial Media Inc.
Terms | Privacy | Guide
tony@aum13f.com